Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study)
About This Grant
Long-acting injectable HIV antiretroviral medications (LAIs) are a breakthrough in HIV treatment and prevention, alleviate daily medication challenges, and are extremely efficacious. While LAIs have the potential to transform and improve health outcomes for people living with HIV or with vulnerability to HIV infection, clinical implementation of LAIs has been suboptimal, including for populations most impacted by HIV. Without evidence-based implementation models that address systems level determinants, the potential for LAIs to help end the HIV epidemic is unlikely to be realized. One approach to meaningfully address health system barriers is by leveraging existing, organically developed efforts designed by system insiders: pharmacists and providers in federally qualified health centers (FQHCs) in the Bronx, NY (a high-priority jurisdiction with >2% HIV prevalence). Currently, clinical pharmacists have organically developed ad hoc implementation efforts where they play an integral role in LAI delivery, including patient counseling, coordination, procurement, cost coverage, delivery, with similar workflows for HIV prevention and treatment using LAIs (i.e., a status-neutral (SN) model). These efforts show promise and warrant systematic study and protocolization to guide potential replication and scale-up. Using rigorous implementation science methods and leveraging expertise from committed multidisciplinary stakeholders (including pharmacists, patients, providers, nurses, administrators, and researchers), this R21 study will develop, formalize, and pilot an embedded SN-LAI implementation model: “Planning for implementation of Long-Acting iNjectables in Status-neutral HIV primary care FQHCs (the PLANS study)”. We will first identify context-specific determinants of SN-LAI implementation and systematically identify existing or perceived barriers and facilitators (Aim1a) using innovative systems journey mapping interviews with patients and key informants. We will use these data to systematically develop, protocolize, and refine a package of SN-LAI implementation strategies with stakeholders (Aim 1b). In a test of concept, we will then pilot strategies for acceptability, feasibility, appropriateness, fidelity, and explore indicators of strategy effectiveness (Aim 2) in a Bronx FQHC to understand the potential of this organically- driven, multidisciplinary approach to overcome system-level barriers and enhance status-neutral LAI implementation.
Grant Summary
Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study) is a NIMH - National Institute of Mental Health grant providing up to $462K for university, nonprofit, healthcare org. Applications are due 2028-05-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $462K
2028-05-31
- 1Confirm your organization is eligible for Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study) from NIMH - National Institute of Mental Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIMH - National Institute of Mental Health before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIMH - National Institute of Mental Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study): Frequently Asked Questions
Who is eligible for the Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study)?
Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study) is offered by NIMH - National Institute of Mental Health and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study) provide?
Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study) provides up to $462K per award from NIMH - National Institute of Mental Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study) deadline?
Applications for Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study) are due 2028-05-31 (open). Because deadlines can change, verify the date with the funder, NIMH - National Institute of Mental Health, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study)?
To apply for Planning for implementation of Long-Acting Injectables in Status-neutral HIV primary care (the PLANS study), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIMH - National Institute of Mental Health.